Cargando…

Measuring the functional impact of cognitive impairment in Huntington’s disease

BACKGROUND: Patients with Huntington’s disease (HD) exhibit a variable predominance of cognitive, behavioral and motor symptoms. A specific instrument focusing on the impact of cognitive impairment in HD over functional capacity is lacking. OBJECTIVE: To address the need for a brief and specifically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horta-Barba, Andrea, Martínez-Horta, Saül, Pérez-Pérez, Jesus, Sampedro, Frederic, Puig-Davi, Arnau, Pagonabarraga, Javier, Kulisevsky, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217879/ https://www.ncbi.nlm.nih.gov/pubmed/35061089 http://dx.doi.org/10.1007/s00415-021-10955-2

Ejemplares similares

Structural brain correlates of dementia in Huntington’s disease
por: Martinez-Horta, Saul, et al.
Publicado: (2020)

Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments
por: Horta-Barba, Andrea, et al.
Publicado: (2023)

Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease
por: Sampedro, Frederic, et al.
Publicado: (2021)

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline
por: Sampedro, Frederic, et al.
Publicado: (2018)

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
por: Kulisevsky, Jaime, et al.
Publicado: (2022)

The Free and Cued Selective Reminding Test in Parkinson's Disease Mild Cognitive Impairment: Discriminative Accuracy and Neural Correlates
por: Horta-Barba, Andrea, et al.
Publicado: (2020)

Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
por: Ruiz-Barrio, Iñigo, et al.
Publicado: (2022)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
por: De Paepe, Audrey E., et al.
Publicado: (2019)

Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease
por: Garcia-Gorro, Clara, et al.
Publicado: (2019)

Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study
por: Martinez-Horta, Saul, et al.
Publicado: (2021)

Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
por: Sampedro, Frederic, et al.
Publicado: (2022)

Facial Emotion Recognition Impairment in Patients with Parkinson's Disease and Isolated Apathy
por: Martínez-Corral, Mercè, et al.
Publicado: (2010)

Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia
por: Sampedro, Frederic, et al.
Publicado: (2020)

Association Between Insulin‐Like Growth Factor‐1 and Social Cognition in Huntington's Disease
por: Gil‐Polo, Cecilia, et al.
Publicado: (2022)

Telling true from false: cannabis users show increased susceptibility to false memories
por: Riba, J, et al.
Publicado: (2015)

Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease
por: Garcia‐Forn, Marta, et al.
Publicado: (2023)

Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
por: Murueta-Goyena, Ane, et al.
Publicado: (2023)

Alterations in Cerebral White Matter and Neuropsychology in Patients with Cirrhosis and Falls
por: Gómez-Ansón, Beatriz, et al.
Publicado: (2015)

Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
por: Pagonabarraga, Javier, et al.
Publicado: (2013)

Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification
por: Gironell, Alexandre, et al.
Publicado: (2018)

Cognitive Dysfunction Contributes to Mobility Impairments in Huntington’s Disease
por: Kloos, Anne D., et al.
Publicado: (2017)

Mild Cognitive Impairment as an Early Landmark in Huntington's Disease
por: Zhang, Ying, et al.
Publicado: (2021)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

EQ-5D-3L for Assessing Quality of Life in Older Nursing Home Residents with Cognitive Impairment
por: Pérez-Ros, Pilar, et al.
Publicado: (2020)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
por: Vinther-Jensen, Tua, et al.
Publicado: (2014)

Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington’s Disease?
por: Grosso Jasutkar, Hilary, et al.
Publicado: (2021)

Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression
por: Hare, Emily, et al.
Publicado: (2022)

Neuroanatomical and Functional Correlates of Cognitive and Affective Empathy in Young Healthy Adults
por: Uribe, Carme, et al.
Publicado: (2019)

Neural Network Aided Detection of Huntington Disease
por: Alfonso Perez, Gerardo, et al.
Publicado: (2022)

Autonomic Changes in Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

Impaired Cerebrovascular Reactivity in Huntington’s Disease
por: Chan, Suk Tak, et al.
Publicado: (2021)

Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
por: Martínez-Horta, Saul, et al.
Publicado: (2021)

Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolism
por: van den Bogaard, Simon J. A., et al.
Publicado: (2011)

Cognitive Reserve in Early Manifest Huntington Disease Patients: Leisure Time Is Associated with Lower Cognitive and Functional Impairment
por: Migliore, Simone, et al.
Publicado: (2022)

Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study
por: Nicoletti, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qe0p9rena02332ne4vb61um15n